$35M Teva QVAR Inhaler Settlement, Check If You Qualify and How to Get Paid July 31 is DeadlineÂ
The Teva QVAR Antitrust Settlement is a $35,000,000 price-fixing class action where eligible consumers and health plan members who purchased QVAR or QVAR Redihaler inhalers can receive a payment by filing a claim before July 31, 2026. Plaintiffs accused Teva Pharmaceutical Industries of illegally blocking cheaper generic versions of QVAR from reaching the market, forcing…
